This work reveals that Rap1 GTPases bind directly to talin1 F1 domain and by cooperating with a unique lipid-dependent amphipathic helix in the F1 domain effects talin1-mediated integrin activation.
Introduction
Integrin receptors are critical mediators of cellular adhesion, migration and assembly of the extracellular matrix, thereby playing an indispensable role in development and in many pathological processes (Hynes, 2002) . Regulation of the affinity of integrins for their ligands is central to their function. In particular, integrins in blood cells are usually expressed in a low-affinity form until intracellular signals initiated by agonists acting via distinct excitatory receptors induces a high-affinity state, a process operationally defined as integrin activation. Binding of talin1 to the cytoplasmic tail of integrin β1 (Shattil et al., 2010; Tadokoro et al., 2003) , β2 (Simonson et al., 2006) , β3 (Haling et al., 2011; Nieswandt et al., 2007; Petrich et al., 2007a; Petrich et al., 2007b) , and β7 ) is a critical final common step in integrin activation.
Talin1 is a large (270 kDa) multi-domain protein that links integrins to the actin cytoskeleton via its N-terminal head domain that binds to the β-integrin cytoplasmic tail and its C-terminal flexible rod domain that binds F-actin (Critchley and Gingras, 2008) .
The talin1 head domain (THD) comprises an atypical FERM domain because it contains an additional F0 domain to the characteristic FERM F1, F2 and F3 domains, and because it adopts a linear arrangement rather than the cloverleaf structure typically observed in other FERM domains (Calderwood et al., 2013) . Talin1 is auto-inhibited in the cytosol due to the interaction of the talin1 head domain (THD) with the rod domain, which prevents the interaction of THD with the integrin β cytoplasmic tail (Song et al., 2012) . Our understanding of the signaling events that regulate talin1 recruitment to the plasma membrane and its association with integrin is incomplete.
Rap1 GTPases are perhaps the most completely studied relays of signals from cell surface receptors to integrin activation. Combined deficiency of both Rap1A and Rap1B isoforms in the megakaryocyte lineage evidenced an essential role for Rap1 signaling in platelet integrin activation and function (Stefanini et al., 2018) . Although the Rap1 effector RIAM plays a major role in recruiting talin1 in leukocytes (Klapproth et al., 2015; Lagarrigue et al., 2017; Su et al., 2015) , its implication in talin1-dependent activation of platelet integrins have been unequivocally ruled out (Klapproth et al., 2015; Stritt et al., 2015; Su et al., 2015) .
Studies using recombinant αIIbβ3-expressing CHO A5 cells revealed that talin1 head domain (THD) induces integrin αIIbβ3 activation in a Rap1-dependent manner , whilst activation by the F2F3 subdomain is Rap1-independent (Han et al., 2006) . This result suggests that a direct interaction between Rap1 and the F0F1 subdomain domain facilitates integrin activation. Structural studies showed that Rap1b binds directly to talin1 F0 domain with low affinity (Goult et al., 2010) .
Furthermore, in Dictyostelium Rap1 directly interacts with the RA domain of talinB (Plak et al., 2016) to enable adhesion during Dictyostelium morphogenesis. Zhu et al. confirmed the direct Rap1-talin1 F0 interaction in mammals and showed that membrane-anchored Rap1b in vesicles has enhanced binding to THD, suggesting a mechanism of talin1 recruitment to integrins by Rap1 (Zhu et al., 2017) . Quantitative proteomic analyses of murine platelets revealed the high abundance of Rap1b and talin1 (Zeiler et al., 2014) . The abundance of the proteins at equal molar ratios and the lack of a known Rap1 effector with such a high abundance in platelets suggest that talin1 F0 domain may act as a direct effector of Rap1 to activate integrins in platelets.
However, we recently reported a talin1 point mutation (R35E) in F0 domain that reduces Rap1 affinity by greater than 25 fold does not impair the capacity of THD to activate integrins in A5 cells nor does it abolish effects of Rap1 activity on THD-induced activation. In accord with this result, Tln1 R35E/R35E mice exhibited similar extent and kinetics of αIIbβ3 activation . Thus, the low affinity Rap1-talin1 F0 interaction does not make a major contribution to integrin activation and cannot account for the profound effects on activation in RIAM-deficient cells of i)loss of Rap1 activity (Stefanini et al., 2018) ; ii) deletion of talin1 (Nieswandt et al., 2007; Petrich et al., 2007b) ; iii) mutations of integrin β3 that block talin1 binding (Petrich et al., 2007a) ; and iv) mutations of talin1 that prevents binding to integrin β3 (Haling et al., 2011) .
Here, we show that talin1 F1 domain contains a previously undiscovered Rap1 binding site of similar affinity to that in F0. A structure-guided mutant in F1, which blocks Rap1 (R35E) combined with the lack of Rap1-dependence of F2F3 mediated integrin activation (Han et al., 2006) , raised the possibility that THD has a second Rap1 binding site.
To assess which THD domain plays a role in the interaction with Rap1 on integrin activation, we generated THD truncations removing either the F0, F1, or F0F1 domains ( Fig. 1C ) and tested effects on integrin activation in A5 cells. Expression of all three THD mutants induced activation (Fig. 1D , black bars), with a markedly lower activation index for THD(∆F1) and THD(∆F0F1), both lacking the F1 domain. Expression of the constitutively activated Rap1b(E63) mutant increased THD(∆F0)-mediated αIIbβ3
activation, but did not affect the activation with THD mutants lacking the F1 domain ( Fig.   1D , red bars). Similarly, inhibition of endogenous Rap1 activity by co-expression of Rap1GAP1 lead to a decrease in THD(∆F0)-mediated activation; thus, the effect of Rap1 activity on integrin activation by THD(∆F0) resembles that observed with THD(wt) . Immunoblotting confirmed similar level of expression for all THD mutants (Fig. 1E ). These data implicated talin1 F1 as a second Rap1-binding site important in integrin activation; a surprising conclusion in light of a previous report that the F1 domain does not to bind Rap1b (Zhu et al., 2017) .
Talin1 F1 domain contains a Rap1 binding site
Since both the talin1 F0 and F1 domains have a ubiquitin fold (Goult et al., 2010) , we aligned their amino-acid sequence and noticed that the key positively charged residues for Rap1 binding are conserved: K15 and R35 in F0, and R98 and R118 in F1 ( Fig. 2A) .
Moreover, superimposition of the NMR structures of the talin1 F0 domain with the F1 domain showed that the position of these residues is conserved. We therefore generated a model of the talin1 F1-Rap1 complex by superimposing the talin1 F1 domain with the F0 domain in complex with Rap1b (Zhu et al., 2017) . We found that the F1 interface with Rap1b to be very similar to that of F0 and to be compatible with R98
and R118 to form salt bridges with the negatively charged groups on Rap1 surface ( contains an RA domain that can bind Rap1b with similar affinity to the talin1 F0 domain (Goult et al., 2010; Lagarrigue et al., 2018; Zhu et al., 2017) .
Reduced affinity of talin1(R118E) F1 domain binding to Rap1
Our molecular modeling suggested that talin1 Arg98 and Arg118 formed crucial salt bridges with Rap1b ( Fig. 2B ) and the NMR data showed they are located at the binding interface. We used the acidic Glu mutations because of the predicted stronger effects of charge repulsions between talin1 F1 and the acidic patch on the surface of Rap1b that mediates their interaction. We therefore purified recombinant 15 N-labelled talin1
F1 (R118E) Thus talin1 F1(R118E) is well folded and has a greatly reduced affinity for Rap1.
Talin1 F1-Rap1b interaction is important for THD-mediated αIIbβ3 activation in

CHO cells
To assess the contribution of the talin1 F0 and F1 interactions with Rap1 on integrin activation, we introduced the mutations R35E, R118E and a double mutant R35E,R118E into the THD (Fig. 3A ) and tested effects on integrin activation in CHO A5
cells. Expression of all THDs induced integrin activation with THD(wt) and THD(R35E) in F0 producing comparable levels of activation. In sharp contrast, both the F1 mutants, THD(R118E) and THD(R35E,R118E), exhibited a dramatically reduced activation (Fig.   3B , black bars). Furthermore, we carefully monitored expression of THD-EGFP and its mutants by flow cytometry and observed a strong effect of the F1 mutants at equivalent levels of THD expression on a per cell basis (Fig. 3C) . Immunoblotting confirmed similar level of global expression for all THD mutants (Fig. 3D ). More importantly, co-expression of both Rap1(E63) and Rap1GAP1 had no effect on integrin activation when the R118E mutation was introduced in the F1 domain (Fig. 3B , red and blue bars). Also, comparison of the THD(wt) activation in the presence of Rap1GAP1 was very similar to the activation index in the presence of THD(R118E) mutant, further supporting the conclusion that the Rap1-F1 interaction is required for talin1 to act as a direct Rap1 effector. Thus, our data showed that the talin1 F1 Rap1-binding site is critical for the capacity of Rap1 to potentiate THD-mediated αIIbβ3 integrin activation in CHO cells.
Talin1 F1-loop is important for THD-mediated αIIbβ3 activation in CHO cells
Since both the talin1 F0 and F1 domains contain a Rap1-binding site with similar affinity for Rap1b in vitro, and that only the THD(R118E) mutant in F1 had an effect on THDmediated αIIbβ3 activation, we examined differences between the two domains. First, the F1 domain is located adjacent to the F2 domain which contains a critical membrane orientation patch required for activation (Anthis et al., 2009) ; however, in THD(∆F1), F0
is adjacent to F2 yet THD(∆F1) exhibits little Rap1-dependence (Fig. 1D) . Secondly, the F1 domain contains an unstructured loop implicated in integrin activation. This loop forms an amphipathic helix upon interacting with lipids. In this helix, basic residues are predicted to reside on the surface of the helix that binds to acidic phospholipids (Goult et al., 2010) .
To assess the contribution of both the talin1 F1 loop and the interaction with Rap1 on integrin activation, we tested integrin activation by THD wherein the loop was removed, THD(∆L) (Fig. 4A ). As previously observed (Goult et al., 2010) , THD(∆L) reduced integrin activation (Fig. 4B , black bars). Importantly, co-expression of both Rap1(E63) and Rap1GAP1 had a negligible effect on integrin activation by THD(∆L) (Fig. 4B, red and blue bars). Furthermore, the double mutant THD(∆L,R118E) resembled THD(∆L).
Immunoblotting confirmed similar level of expression for all THD mutants (Fig. 4C ). 2D-sfHMQC NMR spectra of 15 N-labelled talin1 F1(∆L) exhibited highly dispersed resonances consistent with a stable folded protein (Fig. 4D, blue) . Addition of Rap1b to caused residues specific chemical shift changes of talin1 F1(∆L) (Fig. 4D, red ) that mapped to amino acids located in the predicted RA binding interface including Thr96
and Thr99 (Fig. 4E) . Thus the talin1 F1 loop is important for Rap1-dependence of THDmediated integrin activation but not for Rap1b binding.
Basic residues on the amphipathic helix formed by talin1 F1-loop are important for integrin activation
To further validate the proposed amphipathic helix mechanism whereby the talin1 F1 loop plays a role in integrin activation, we introduced three charge reversal mutations in basic residues of the amphipathic helix (R146E,R153E,K156E (3EL)) to create a charge repulsion with the negatively charged PI(4,5)P2 of the plasma membrane (Fig. 5A ).
THD(3EL) was even less active than THD(∆L) in activating αIIbβ3 (Fig. 5B) .
Immunoblotting confirmed similar level of expression for all THD mutants (Fig. 5C ). The studies reported here provide new insight into how talin1 activates integrins, a process central to mammalian development and numerous physiological functions.
Studies in A5 cells led to the conclusion that talin1 is required for integrin activation, established the importance of specific structural elements in the integrin and in THD, and identified the importance of lipid binding residues (Anthis et al., 2009; Goult et al., 2010; Tadokoro et al., 2003; Wegener et al., 2007) . The cells were also instrumental in studies that showed how Rap1, by engaging RIAM enabled RIAM to recruit talin1 to integrins (Han et al., 2006; Lee et al., 2009 ); a key pathway in leukocyte trafficking and formation of the immune synapse (Lagarrigue et al., 2017) . Nevertheless, Rap1 can activate integrins in the absence of RIAM or of obvious candidate effectors. Goult's pioneering studies suggested that talin1 F0 could enable talin1 to itself be an effector (Goult et al., 2010) , an idea further advanced by Zhu et al. 2017 ; however we found that the F0 domain made a minor (if any) contribution. We now find that the F1 domain contains a second Rap1 binding site and that this site functions in conjunction with a unique inserted loop to enable Rap1 to regulate activation. The proximity of the putative membrane binding helix of the loop to the geranyl-geranyl moiety of Rap1 bound to F1 provides a cogent model to explain the cooperative behavior of these two membrane binding sites in integrin activation (Fig. 5D) . Indeed, the now more complete picture of how THD interacts with the membrane shows that an extended series of membrane binding sites serve to stabilize the weak interaction of talin1 F3 with the integrin β cytoplasmic domain to explain the membrane dependence of talin1-induced activation (Ye et al., 2010) . Our studies show how Rap can add to those membrane-binding sites to enable activation in the absence of effectors such as RIAM. We note that Rap1 binding to both F0 and F1 could also serve to stabilize the talin1-membrane interaction to help talin1 resist cell detachment forces. Thus, our findings will enable future studies to characterize the role of each of these Rap1 binding sites in activation in cells in which talin1 and Rap1 are in varying abundance and to assess their roles in stability of integrin-mediated adhesions and resulting mechanotransduction.
Materials and methods
Integrin activation in CHO cells
Cells were cultured in DMEM (Corning) supplemented with 10% fetal bovine serum (Sigma-Aldrich), and 100 U/ml penicillin and 100 μg/ml streptomycin (Gibco). The sequence encoding murine talin1 head domain (THD, aa 1-433) was cloned into pEGFP-N1 (Clontech). The sequences encoding human Rap1b(Q63E) and Rap1GAP1
were cloned into p3xFlag7.1(-) (Clontech). Transient transfection was performed using
TransIT-LT1 Reagent (Mirus) according to the manufacturer's protocol. PAC-1 binding assay was conducted as previously described (Frojmovic et al., 1991) . Briefly, cells were harvested by using trypsin one day after transfection and washed once in HBSS buffer Integrin activation was defined as αIIbβ3 specific ligand binding corrected for αIIbβ3
expression, and was calculated as 100x(MFIi-MFI0)/ΔMFID57 (where MFIi = mean fluorescence intensity of bound PAC-1; MFI0 = mean fluorescence intensity of bound PAC-1 in the presence of 10 μM Eptifibatide; and ΔMFID57 = specific fluorescence intensity of anti-αIIbβ3 D57 antibody). PAC1 (Shattil et al., 1985) and D57 (O'Toole et al., 1994 ) antibodies have been previously described.
Protein expression and purification
The murine talin1 residues 1-400 (THD), 84-196 (F1) , and 84-196 ∆141-170 (F1 ∆loop)
were cloned into the expression vector pETM-11 (His-tagged, EMBL) and expressed in Untagged Rap1b was purified by ion exchange, followed by Superdex-75 (26/600) gel filtration as previously described (Gingras et al., 2016) . The column was pre-equilibrated and run with NMR-buffer. (HN,N) ) were calculated using CcpNmr Analysis, "follow shift changes" function and analyzed with the one site binding model to determine the Kd value in Prism 5.0 (GraphPad Software) (Vranken et al., 2005) .
NMR spectroscopy
Western blotting
Cells were lysed in Laemmli sample buffer. Lysates were subjected to a 4-20% gradient SDS-PAGE. Polyclonal serum directed against EGFP was raised in rabbit (Abgent).
Antibody against β-actin (AC-15) was from Sigma-Aldrich. The appropriate IRDye/Alexa
Fluor-coupled secondary antibodies were from LI-COR. Nitrocellulose membranes were scanned using an Odyssey CLx infrared imaging system (LI-COR) and blots were processed using Image Studio Lite software (LI-COR).
Reagents
GMP.PNP was purchased from Sigma. Actin was used as a loading control. Figure 5
Statistical analysis
